Kidron
Kidron Capital is an Israel-based, early-stage venture capital firm investing in women's health and sex-specific biology across devices, diagnostics, digital health, care delivery, and therapeutics, currently raising its second fund.
- Company typePrivate
- Founded2021
- HeadquartersTel Aviv, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Kidron does
Kidron Capital Assets LP is a specialist early-stage healthcare venture capital firm headquartered in Tel Aviv, Israel, founded in 2021 by Dr. Anula Jayasuriya and Maria Gajda Horowitz as Founding Managing Partners. The firm invests in companies where sex-specific biology, unmet clinical need, and inefficient capital allocation create overlooked opportunities across five verticals: medical devices, diagnostics, digital health, care delivery, and therapeutics, all targeted at women's health conditions.
The firm operates as a conventional emerging-manager venture fund structure rather than a technology platform. Its differentiated offering is investment thesis depth and clinical rigor in women's health, paired with cross-border deal access. The firm deploys capital directly into portfolio companies through equity investments from its venture funds and is currently raising Fund II, its second dedicated women's health fund, following Fund I.
Revenue mechanics follow the standard VC model: management fees on committed/invested capital plus carried interest on successful exits. The firm markets itself via direct investor outreach ([email protected]) and a specialist positioning emphasizing "specialist focus, clinical rigor, cross-border access." No proprietary technology, AI tools, or non-fund revenue streams are described; the entire operating model is fund management and equity returns.
Kidron firmographics
Firmographics- Name
- Kidron
- Legal name
- Kidron Capital
- Website
- https://kidron-capital.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Kidron Capital is an Israel-based, early-stage venture capital firm investing in women's health and sex-specific biology across devices, diagnostics, digital health, care delivery, and therapeutics, currently raising its second fund.
- Ownership category
- akta.pro rank
Kidron industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Other Financial Investment Activities (5239)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Kidron is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Markets served
Kidron business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales
Revenue model
- Fund Management / VC Returns: As a venture capital firm raising Fund II, Kidron Capital generates returns through equity investments in early-stage women's health companies. Revenue is derived from fund management fees and carried interest on successful portfolio exits.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Kidron product offering
Product offeringCore offering
Kidron Capital is a specialist early-stage healthcare venture capital firm that deploys capital into companies focused on women's health and sex-specific biology. The firm invests across medical devices, diagnostics, digital health, care delivery, and therapeutics, targeting opportunities where sex-specific biology, unmet clinical need, and inefficient capital allocation intersect. Currently raising Fund II.
Product overview
Kidron Capital is a specialist venture capital firm (not a technology product company). The firm operates as a unified investment offering, deploying capital from its early-stage healthcare fund into women's health companies. Rather than a platform with modular products, Kidron's 'offering' consists of its investment strategy, clinical expertise, and cross-border access capabilities. The firm is currently raising its second fund (Fund II).
Differentiator
Problem solved
Functional benefit
Products and services
- Kidron Capital Fund II Specialist early-stage healthcare venture fund deploying equity capital into women's health and sex-specific biology companies across medical devices, diagnostics, digital health, care delivery, and therapeutics. The fund is currently raising.
Companies that use Kidron
Customer profileSegments1 record
Ideal customer profiles2 records
Kidron technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Kidron partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Kidron competitors and assessment
Company assessmentDirect peers
- Female Founders Fund: Early-stage venture fund with a mandate focused on women-led and women-serving companies. Directly comparable to Kidron because both operate specialist mandates at the intersection of gender-focused investing and early-stage venture, though Female Founders Fund is sector-agnostic while Kidron narrows further to women's health.
- Rhia Ventures: Venture and impact fund focused on reproductive and women's health. Closely comparable to Kidron's sex-specific biology and unmet clinical need thesis, with similar early-stage orientation and LP base overlap.
- Define Ventures: Early-stage venture firm focused on healthcare technology and digital health. Comparable as a specialist early-stage healthcare investor with deep operating expertise, though broader than Kidron's women's health focus.
- Genoa Ventures: Early-stage venture firm focused on life sciences, including diagnostics and women's health. Comparable because of its specialist early-stage life sciences/healthcare mandate and similar size/emerging-manager profile.
- aMoon Ventures: Israeli healthtech and biotech venture fund. Highly comparable because it shares Kidron's Tel Aviv base and operates as a specialist Israeli healthcare investor, though with larger AUM and broader healthcare scope.
- Peregrine Ventures: Israeli early-stage healthcare and medtech investor. Comparable regional specialist healthcare peer with similar thesis on underfunded Israeli healthtech innovation.
Emerging players
- Rock Health: Venture fund and advisory focused exclusively on digital health. Comparable because of the digital-health adjacency to Kidron's digital health investment bucket, though Rock Health is broader and more digital-only.
Broad incumbents
- Lux Capital: Established venture firm with deep healthcare and life sciences practice. Comparable as a competitor for healthcare deals, but operates at much larger scale and across sectors beyond women's health.
- Khosla Ventures: Large venture firm with broad healthcare and biotech practice. Comparable as a competitive bidder for women's health deals, but with substantially larger fund sizes and broader sector exposure.
- New Enterprise Associates (NEA): Large venture firm with significant healthcare practice. Comparable as a competitor for early-stage healthcare rounds, though far broader and with much deeper capital reserves than Kidron.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Kidron social profiles
Digital presenceKidron financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kidron leadership team
Management profileNumber of profiles
Profiles2 records
Kidron funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kidron M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kidron
What does Kidron do?
Kidron Capital is a specialist early-stage healthcare venture capital firm that deploys capital into companies focused on women's health and sex-specific biology. The firm invests across medical devices, diagnostics, digital health, care delivery, and therapeutics, targeting opportunities where sex-specific biology, unmet clinical need, and inefficient capital allocation intersect. Currently raising Fund II.
Is Kidron a public or private company?
Kidron is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Kidron founded?
Kidron was founded in 2021. It employs 1 to 10 people.
Where is Kidron based?
Kidron is headquartered in Tel Aviv, Israel, in the Middle East region.
How does Kidron make money?
One revenue line is on record: fund Management / VC Returns.
Who are Kidron's main competitors?
Direct peers on record are Female Founders Fund, Rhia Ventures, Define Ventures, Genoa Ventures, aMoon Ventures and Peregrine Ventures. Rock Health is listed as an emerging player. Broad incumbents are Lux Capital, Khosla Ventures and New Enterprise Associates (NEA).
Does Kidron have an API?
No public API is recorded for Kidron.
What industry is Kidron in?
Kidron's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.